Analyst	Recommendation	Action	Price target	Projected	Date
Matthew Weber Canaccord Genuity	Buy	Maintained	$22.00	+51.8%	11/03/2026
Ryan Sigdahl Craig-Hallum	Buy	Maintained	$18.00	+24.2%	11/04/2026
Jeffrey Stantial Stifel Nicolaus	Buy	Maintained	$17.00	+17.3%	11/04/2026
Trey Bowers Wells Fargo	Hold	Maintained	$14.00	-3.4%	11/04/2026
Clark Lampen BTIG	Hold	Maintained	-	-	11/03/2026
Curry Baker Guggenheim	Buy	Reiterated	$23.00	+58.7%	11/03/2026
Eric Handler Roth MKM	Buy	Maintained	$19.00	+31.1%	11/04/2026
Samuel Nielsen J.P. Morgan	Hold	Maintained	$12.00	-17.2%	11/04/2026
Jordan Bender Citizens JMP	Buy	Maintained	$19.00	+31.1%	11/04/2026
Jason Tilchen Canaccord Genuity	Buy	Reiterated	$22.00	+51.8%	10/23/2026
Shaun Kelley Bank of America Securities	Buy	Maintained	$16.00	+10.4%	10/19/2026
Stephen Grambling Morgan Stanley	Hold	Reiterated	$13.50	-6.8%	10/19/2026
Peter Supino Wolfe Research	Buy	Initiated	$22.00	+51.8%	09/02/2026
Mike Hickey StoneX	Buy	Maintained	$14.00	-3.4%	08/28/2026
David Katz Jefferies	Hold	Maintained	$14.00	-3.4%	08/27/2026
Robin M. Farley UBS	Hold	Downgraded	$16.00	+10.4%	08/05/2026
Barry Jonas Truist Financial	Buy	Maintained	$16.00	+10.4%	08/04/2026
Eric Sheridan Goldman Sachs	Hold	Maintained	$14.50	+0.1%	08/04/2026
Jason Bazinet Citi	Buy	Maintained	$20.00	+38%	08/04/2026
Stephen Powers Deutsche Bank	Buy	Reiterated	$16.00	+10.4%	08/04/2026
Bernie McTernan Needham	Buy	Reiterated	$17.00	+17.3%	08/04/2026
Unknown Analyst Freedom Capital Markets	Buy	Initiated	-	-	07/20/2026
Nick McKay Freedom Capital Markets	Buy	Initiated	$20.00	+38%	07/20/2026
James Wheatcroft Jefferies	Hold	Downgraded	$14.00	-3.4%	04/24/2026

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	292.05M	368.89M	346.52M	377.82M
Cost of goods sold	199.30M	258.50M	269.02M	282.15M
Cost of revenue	199.30M	258.50M	269.02M	282.15M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	9.85M	-	-
Operating expense	38.81M	50.60M	48.93M	57.87M
Total operating expenses	238.11M	309.10M	317.96M	340.02M
Operating income	53.94M	59.79M	28.56M	37.79M
Other non operating income	-	644.00K	-	-
EBT including unusual items	29.15M	-1.18M	-4.87M	-3.87M
EBT excluding unusual items	36.44M	37.11M	-1.74M	7.60M
Income tax expense	6.68M	-5.59M	1.42M	-351.00K
Effective tax rate	22.92%	471.79%	-29.20%	9.07%
Other operating expenses	21.70M	17.78M	27.08M	35.25M
Net income	22.47M	4.40M	-6.29M	-3.52M
Net profit margin	7.69%	1.19%	-1.81%	-0.93%
Earnings per share	0.12	0.20	-0.01	0.04
Interest and investment income	2.53M	2.53M	3.29M	2.31M
Interest expense	-20.38M	-22.96M	-24.32M	-23.38M
Net interest expenses	-17.84M	-20.43M	-21.03M	-21.06M
Depreciation and amortization charges	16.34M	17.16M	19.53M	21.34M
EBITDA	110.44M	110.60M	136.22M	159.35M
Gain or loss from assets sale	-	-	-	-

Ask anything